COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis
NYSE:CHCT - New York Stock Exchange, Inc. - US20369C1062 - REIT
Overall CHCT gets a fundamental rating of 4 out of 10. We evaluated CHCT against 129 industry peers in the Diversified REITs industry. There are concerns on the financial health of CHCT while its profitability can be described as average. CHCT shows excellent growth, but is valued quite expensive already. Finally CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT was profitable.
In the past year CHCT had a positive cash flow from operations.
In the past 5 years CHCT has always been profitable.
Each year in the past 5 years CHCT had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -0.01%, CHCT perfoms like the industry average, outperforming 42.06% of the companies in the same industry.
CHCT has a Return On Equity of -0.03%. This is comparable to the rest of the industry: CHCT outperforms 42.86% of its industry peers.
With a decent Return On Invested Capital value of 3.38%, CHCT is doing good in the industry, outperforming 67.46% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHCT is in line with the industry average of 3.11%.
The last Return On Invested Capital (3.38%) for CHCT is above the 3 year average (2.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.01% | ||
| ROE | -0.03% | ||
| ROIC | 3.38% |
ROA(3y)1.8%
ROA(5y)1.84%
ROE(3y)3.07%
ROE(5y)3.04%
ROIC(3y)2.91%
ROIC(5y)2.96%
1.3 Margins
In the last couple of years the Profit Margin of CHCT has declined.
CHCT's Operating Margin of 28.41% is fine compared to the rest of the industry. CHCT outperforms 61.90% of its industry peers.
In the last couple of years the Operating Margin of CHCT has declined.
CHCT's Gross Margin of 80.17% is fine compared to the rest of the industry. CHCT outperforms 78.57% of its industry peers.
CHCT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.41% | ||
| PM (TTM) | N/A | ||
| GM | 80.17% |
OM growth 3Y-15.52%
OM growth 5Y-4.28%
PM growth 3Y-41.7%
PM growth 5Y-8.07%
GM growth 3Y-0.15%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHCT is destroying value.
CHCT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHCT has more shares outstanding
Compared to 1 year ago, CHCT has a worse debt to assets ratio.
2.2 Solvency
CHCT has an Altman-Z score of 1.07. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
CHCT's Altman-Z score of 1.07 is fine compared to the rest of the industry. CHCT outperforms 74.60% of its industry peers.
A Debt/Equity ratio of 1.00 indicates that CHCT is somewhat dependend on debt financing.
CHCT has a Debt to Equity ratio of 1.00. This is comparable to the rest of the industry: CHCT outperforms 57.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.07 |
ROIC/WACC0.49
WACC6.89%
2.3 Liquidity
CHCT has a Current Ratio of 0.51. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
CHCT's Current ratio of 0.51 is on the low side compared to the rest of the industry. CHCT is outperformed by 87.30% of its industry peers.
A Quick Ratio of 0.16 indicates that CHCT may have some problems paying its short term obligations.
With a Quick ratio value of 0.16, CHCT is not doing good in the industry: 98.41% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.16 |
3. Growth
3.1 Past
CHCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.45%, which is quite impressive.
The Earnings Per Share has been growing slightly by 1.25% on average over the past years.
The Revenue has grown by 32.89% in the past year. This is a very strong growth!
The Revenue has been growing by 18.37% on average over the past years. This is quite good.
EPS 1Y (TTM)45.45%
EPS 3Y-39.18%
EPS 5Y1.25%
EPS Q2Q%-63.64%
Revenue 1Y (TTM)32.89%
Revenue growth 3Y14.24%
Revenue growth 5Y18.37%
Sales Q2Q%3.15%
3.2 Future
The Earnings Per Share is expected to grow by 43.37% on average over the next years. This is a very strong growth
Based on estimates for the next years, CHCT will show a quite strong growth in Revenue. The Revenue will grow by 11.35% on average per year.
EPS Next Y-168%
EPS Next 2Y44.8%
EPS Next 3Y43.37%
EPS Next 5YN/A
Revenue Next Year2.18%
Revenue Next 2Y4.83%
Revenue Next 3Y6.37%
Revenue Next 5Y11.35%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 60.94 indicates a quite expensive valuation of CHCT.
The rest of the industry has a similar Price/Earnings ratio as CHCT.
The average S&P500 Price/Earnings ratio is at 28.19. CHCT is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 51.67, CHCT can be considered very expensive at the moment.
CHCT's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CHCT to the average of the S&P500 Index (24.37), we can say CHCT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.94 | ||
| Fwd PE | 51.67 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHCT indicates a somewhat cheap valuation: CHCT is cheaper than 70.63% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.52 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CHCT's earnings are expected to grow with 43.37% in the coming years.
PEG (NY)N/A
PEG (5Y)48.77
EPS Next 2Y44.8%
EPS Next 3Y43.37%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 9.37%, CHCT is a good candidate for dividend investing.
CHCT's Dividend Yield is rather good when compared to the industry average which is at 18.51. CHCT pays more dividend than 88.10% of the companies in the same industry.
CHCT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.37% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.33%.
CHCT has paid a dividend for at least 10 years, which is a reliable track record.
CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.33%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
CHCT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-40144.09%
EPS Next 2Y44.8%
EPS Next 3Y43.37%
COMMUNITY HEALTHCARE TRUST I
NYSE:CHCT (1/22/2025, 6:40:00 PM)
After market: 19.5 0 (0%)19.5
-0.69 (-3.42%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners91.82%
Inst Owner Change-0.17%
Ins Owners4.85%
Ins Owner Change7.23%
Market Cap550.68M
Analysts81.82
Price Target21.62 (10.87%)
Short Float %2.9%
Short Ratio2.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.37% |
Yearly Dividend1.8
Dividend Growth(5Y)2.33%
DP-40144.09%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-65.45%
Min EPS beat(2)-86.93%
Max EPS beat(2)-43.98%
EPS beat(4)0
Avg EPS beat(4)-43.24%
Min EPS beat(4)-86.93%
Max EPS beat(4)-1.96%
EPS beat(8)1
Avg EPS beat(8)-58.95%
EPS beat(12)1
Avg EPS beat(12)-43.65%
EPS beat(16)1
Avg EPS beat(16)-36.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.39%
Min Revenue beat(2)-11.19%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-4.94%
Min Revenue beat(4)-11.19%
Max Revenue beat(4)-1.59%
Revenue beat(8)1
Avg Revenue beat(8)-3.39%
Revenue beat(12)1
Avg Revenue beat(12)-3%
Revenue beat(16)4
Avg Revenue beat(16)-2.1%
PT rev (1m)1.92%
PT rev (3m)-4.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-58.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.31%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)-1.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.94 | ||
| Fwd PE | 51.67 | ||
| P/S | 3.8 | ||
| P/FCF | N/A | ||
| P/OCF | 9.58 | ||
| P/B | 1.15 | ||
| P/tB | 1.16 | ||
| EV/EBITDA | 12.52 |
EPS(TTM)0.32
EY1.64%
EPS(NY)0.38
Fwd EY1.94%
FCF(TTM)-1.44
FCFYN/A
OCF(TTM)2.04
OCFY10.44%
SpS5.13
BVpS16.9
TBVpS16.82
PEG (NY)N/A
PEG (5Y)48.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.01% | ||
| ROE | -0.03% | ||
| ROCE | 4.27% | ||
| ROIC | 3.38% | ||
| ROICexc | 3.39% | ||
| ROICexgc | 3.45% | ||
| OM | 28.41% | ||
| PM (TTM) | N/A | ||
| GM | 80.17% | ||
| FCFM | N/A |
ROA(3y)1.8%
ROA(5y)1.84%
ROE(3y)3.07%
ROE(5y)3.04%
ROIC(3y)2.91%
ROIC(5y)2.96%
ROICexc(3y)2.93%
ROICexc(5y)2.97%
ROICexgc(3y)2.99%
ROICexgc(5y)3.02%
ROCE(3y)3.69%
ROCE(5y)3.75%
ROICexcg growth 3Y-13.67%
ROICexcg growth 5Y-4.37%
ROICexc growth 3Y-14.13%
ROICexc growth 5Y-3.19%
OM growth 3Y-15.52%
OM growth 5Y-4.28%
PM growth 3Y-41.7%
PM growth 5Y-8.07%
GM growth 3Y-0.15%
GM growth 5Y0.53%
F-Score4
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.72 | ||
| Cap/Depr | 232.25% | ||
| Cap/Sales | 67.66% | ||
| Interest Coverage | 1.7 | ||
| Cash Conversion | 68.95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.16 | ||
| Altman-Z | 1.07 |
F-Score4
WACC6.89%
ROIC/WACC0.49
Cap/Depr(3y)313.87%
Cap/Depr(5y)432.65%
Cap/Sales(3y)106.44%
Cap/Sales(5y)149.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.45%
EPS 3Y-39.18%
EPS 5Y1.25%
EPS Q2Q%-63.64%
EPS Next Y-168%
EPS Next 2Y44.8%
EPS Next 3Y43.37%
EPS Next 5YN/A
Revenue 1Y (TTM)32.89%
Revenue growth 3Y14.24%
Revenue growth 5Y18.37%
Sales Q2Q%3.15%
Revenue Next Year2.18%
Revenue Next 2Y4.83%
Revenue Next 3Y6.37%
Revenue Next 5Y11.35%
EBIT growth 1Y69.7%
EBIT growth 3Y-3.49%
EBIT growth 5Y13.31%
EBIT Next Year234.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-656.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.94%
OCF growth 3Y8.27%
OCF growth 5Y20.22%